Read + Share
Amedeo Smart
Independent Medical Education
Callahan MK, Chapman PB. PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma. J Clin Oncol 2022 Jan 14:JCO2102801. doi: 10.1200/JCO.21.02801.PMID: 35030031
Email
LinkedIn
Facebook
Twitter
Privacy Policy